The US Food and Drug Administration has approved the ultrasound-based Paradise renal denervation system for the treatment of hypertension, marking the culmination of more than a decade of work—with ...

Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...

Credit: Medtronic. The Simplicity Spyral RDN system is designed to lower BP by delivering radiofrequency energy through the wall of the renal artery to denervate the kidney from sympathetic nerve ...

Renal denervation (RDN) was among the most prevalent and buzzed-about topics pumping up the crowd at this year's European Society of Cardiology (ESC) Congress 2012. And in light of the parade of ...

TOKYO--(BUSINESS WIRE)--Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) and Recor Medical, Inc. (“Recor”, subsidiary of Otsuka Medical Devices) announced the U.S. Food and Drug ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The latest edition of the United States Renal Data ...

Despite the availability of effective therapies for patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large-scale trials examining ...

When irreversible damage to your kidneys prevents them from functioning enough to support your body’s needs, your doctor may recommend a bilateral nephrectomy. This is the surgical removal of both ...